N-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide

C56H69N13O8S — CID 167018754

IUPACN-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide
SMILESCCOc1cc(N2CCC(C(=O)N3CCN(Cc4ccc(-n5c(C(=O)NCCN(CC)CC)nnc5-c5cc(C(C)C)c(O)cc5O)cc4)CC3)CC2)ccc1Nc1ncc2c(n1)N(S(C)(=O)=O)c1ccccc1C(=O)N2C
InChIInChI=1S/C56H69N13O8S/c1-8-64(9-2)26-23-57-53(72)52-62-61-50(43-32-42(36(4)5)47(70)33-48(43)71)68(52)39-17-15-37(16-18-39)35-65-27-29-67(30-28-65)54(73)38-21-24-66(25-22-38)40-19-20-44(49(31-40)77-10-3)59-56-58-34-46-51(60-56)69(78(7,75)76)45-14-12-11-13-41(45)55(74)63(46)6/h11-20,31-34,36,38,70-71H,8-10,21-30,35H2,1-7H3,(H,57,72)(H,58,59,60)
InChIKeyOUXYGSDZZGEYRA-UHFFFAOYSA-N
MW1084.32 g/mol
LogP6.72
Rot. Bonds18

About N-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide

N-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide (PubChem CID 167018754) has the molecular formula C56H69N13O8S and a molecular weight of 1084.32 g/mol. Its IUPAC name is N-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide.

Molecular Properties

Compound NameN-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide
PubChem CID167018754
Molecular FormulaC56H69N13O8S
Molecular Weight1084.32 g/mol
Exact Mass1083.51
IUPAC NameN-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide
SMILESCCOc1cc(N2CCC(C(=O)N3CCN(Cc4ccc(-n5c(C(=O)NCCN(CC)CC)nnc5-c5cc(C(C)C)c(O)cc5O)cc4)CC3)CC2)ccc1Nc1ncc2c(n1)N(S(C)(=O)=O)c1ccccc1C(=O)N2C
InChIInChI=1S/C56H69N13O8S/c1-8-64(9-2)26-23-57-53(72)52-62-61-50(43-32-42(36(4)5)47(70)33-48(43)71)68(52)39-17-15-37(16-18-39)35-65-27-29-67(30-28-65)54(73)38-21-24-66(25-22-38)40-19-20-44(49(31-40)77-10-3)59-56-58-34-46-51(60-56)69(78(7,75)76)45-14-12-11-13-41(45)55(74)63(46)6/h11-20,31-34,36,38,70-71H,8-10,21-30,35H2,1-7H3,(H,57,72)(H,58,59,60)
InChIKeyOUXYGSDZZGEYRA-UHFFFAOYSA-N
XLogP6.72
TPSA235.03 Ų
H-Bond Donors4
H-Bond Acceptors17
Rotatable Bonds18
Heavy Atoms78
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001084.32
LogP ≤ 56.72
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}

Analyze N-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide?
The IUPAC name of N-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide (CID 167018754) is N-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide.
What is the SMILES notation for N-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide?
The canonical SMILES for N-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide is CCOc1cc(N2CCC(C(=O)N3CCN(Cc4ccc(-n5c(C(=O)NCCN(CC)CC)nnc5-c5cc(C(C)C)c(O)cc5O)cc4)CC3)CC2)ccc1Nc1ncc2c(n1)N(S(C)(=O)=O)c1ccccc1C(=O)N2C.
What is the InChIKey of N-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide?
The InChIKey is OUXYGSDZZGEYRA-UHFFFAOYSA-N. The full InChI is InChI=1S/C56H69N13O8S/c1-8-64(9-2)26-23-57-53(72)52-62-61-50(43-32-42(36(4)5)47(70)33-48(43)71)68(52)39-17-15-37(16-18-39)35-65-27-29-67(30-28-65)54(73)38-21-24-66(25-22-38)40-19-20-44(49(31-40)77-10-3)59-56-58-34-46-51(60-56)69(78(7,75)76)45-14-12-11-13-41(45)55(74)63(46)6/h11-20,31-34,36,38,70-71H,8-10,21-30,35H2,1-7H3,(H,57,72)(H,58,59,60).
What are the key properties of N-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide?
N-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide has a molecular weight of 1084.32 g/mol, XLogP of 6.72, 18 rotatable bonds, 4 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(diethylamino)ethyl]-5-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-[4-[[4-[1-[3-ethoxy-4-[(5-methyl-11-methylsulfonyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]piperidine-4-carbonyl]piperazin-1-yl]methyl]phenyl]-1,2,4-triazole-3-carboxamide is sourced from PubChem (CID 167018754), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).